Analysis reveals that drug shortages in oncology lead to suboptimal patient outcomes, suggesting focus on prevention.
Shortages of oncology medications have unique complications for dedicated cancer centers and comprehensive cancer centers. Mitigation solutions for medication shortages at these types of health systems can help extend supply and decrease existing demand run rates, but these shortages can eventually lead to suboptimal patient outcomes. Health care’s collective focus should be on ending drug shortages, not mitigating them.
No takes yet. Share an insight, caveat, or question.
Kenneth M. Komorny (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: